Gilead (GILD) reported positive results from a pivotal Phase 3 study of its twice-yearly HIV prevention treatment lenacapavir ...
With an array of new medicines and medical devices on display, global medical companies are looking to tap further into the ...
With an array of new medicines and medical devices on display global medical companies are looking to tap further into the ...
"China market is one of the most attractive markets for Edwards," said Leo Tam, senior director of the business unit of Transcatheter Aortic Valve Replacement, Edwards Lifesciences China, citing a lot ...